Cargando…
Niclosamide suppresses T-cell acute lymphoblastic leukemia growth through activation of apoptosis and autophagy
T-cell acute lymphoblastic leukemia (T-ALL) is a common pediatric malignancy, characterized by the abnormal presence of immature T-cell progenitors. Conventional treatments for T-ALL fail to prevent or cure the disease, with a high-risk of recurrence after the first remission. Thus, medical options...
Autores principales: | Huang, Fang-Liang, Yu, Sheng-Jie, Liao, En-Chih, Li, Long-Yuan, Shen, Pei-Wen, Li, Chia-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717126/ https://www.ncbi.nlm.nih.gov/pubmed/34913075 http://dx.doi.org/10.3892/or.2021.8241 |
Ejemplares similares
-
Role of Autophagy and Apoptosis in Acute Lymphoblastic Leukemia
por: Huang, Fang-Liang, et al.
Publicado: (2021) -
Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: Molecular pathways and disease treatments
por: Huang, Fang-Liang, et al.
Publicado: (2020) -
High G9a Expression in DLBCL and Its Inhibition by Niclosamide to Induce Autophagy as a Therapeutic Approach
por: Hsu, Chin-Mu, et al.
Publicado: (2023) -
Niclosamide suppresses acute myeloid leukemia cell proliferation through inhibition of CREB-dependent signaling pathways
por: Chae, Hee-Don, et al.
Publicado: (2017) -
The magic bullet: Niclosamide
por: Jiang, Haowen, et al.
Publicado: (2022)